ÍøºìºÚÁÏ

Skip to main content
(352) 265-4845

Mark S Segal, MD, PhD : Research

Nephrologist (Kidney Specialist)

Photo of Mark S Segal
(352) 265-4845 MyUFÍøºìºÚÁÏ

Research at a glance

Top areas of exploration

  • Cells, Cultured , 19 publications
  • Biomarkers , 17 publications
  • Kidney Failure, Chronic , 16 publications
  • Hypertension , 16 publications

Research activity

161 publications

10,466 citations

Why is this important?

Active clinical trials

HyperQure RDN System

HQ-HTN-G01 is a prospective, multicenter, single arm, open label, early feasibility study to evaluate initial safety and device design concept of "HyperQureTM RDN System", laparoscopic renal denervation therapy, in patients with resistant…

Investigator
Mark S Segal
Status
Accepting Candidates
Ages
22 Years - 80 Years
Sexes
All
EASi-KIDNEY
Investigator
Mark S Segal
Status
Accepting Candidates
REGEN-006

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys in participants with…

Investigator
Mark S Segal
Status
Accepting Candidates
Ages
30 Years - 80 Years
Sexes
All

My publications

161 publications

2011

Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study.

Arthritis research & therapy

•

2011

Relaxin induces rapid dilation of rodent small renal and human subcutaneous arteries via PI3 kinase and nitric oxide.

Endocrinology

•

2011

Screening prevalence and incidence of colorectal cancer among American Indian/Alaskan natives in the Indian ÍøºìºÚÁÏ Service.

Digestive diseases and sciences

•

2011

The relative importance of predictors of body mass index change, overweight and obesity in adolescent girls.

International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity

•

2010

Endogenous type-I interferon activity is not associated with depression or fatigue in systemic lupus erythematosus.

Journal of neuroimmunology

•